Mouth cancer

A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

Men are more than twice as likely as women to develop oral cancer, according to new figures released by Cancer Research UK today (Wednesday).

There’s more to stopping cancer from spreading than simply cutting out chocolate, despite what the headlines say.

We spoke to Charlie, a mouth cancer survivor, about the importance of spotting the disease early.

A new Cancer Research UK analysis reveals that rates of mouth (oral) cancer have jumped by 68 per cent in the UK over the last 20 years.

Professor Richard Shaw, a mouth cancer specialist who helped create our new Oral Cancer Toolkit, explains why it differs from the NICE referral guidelines

We explore the reasons behind the nation’s rising rates of mouth cancer.

Oral cancer is now the tenth most common cancer in men according to new figures released by Cancer Research UK today.

Emma Shanks shares her story of being diagnosed with oral cancer, not once but four times in succession.